Page 91 - AN-2-3
P. 91

Advanced Neurology                                      Dysregulation of cAMP signaling pathway in MT2KO mice



            PKA . It has been reported that the knockdown of EPAC2   Availability of data
                [35]
            inhibits dendritic spine morphology and suppresses
                         [36]
            synaptic density . Our results showed abnormal dendritic   The  original  and  supporting  data  can  be  obtained  from
            spine morphology, decreased synaptic density, and   corresponding author following formal request.
            significantly more immature synapses in MT2KO mice,   References
            suggesting that decreased EPAC2 expression may also be
            involved in cognitive impairment in MT2KO mice.    1.   Dubocovich ML, 2007, Melatonin receptors: Role on sleep
                                                                  and circadian rhythm regulation. Sleep Med, 8: 34–42.
            5. Conclusion                                         https://doi.org/10.1016/j.sleep.2007.10.007

            Based on our findings, we believe that the decreased   2.   Masana MI, Dubocovich ML, 2001, Melatonin receptor
            expression of the melatonin receptor and the impairment   signaling: Finding the path through the dark.  Sci STKE,
            of its signal transduction may play a critical role in AD   2001: pe39.
            pathology. These molecular alterations could help us      https://doi.org/10.1126/stke.2001.107.pe39
            unravel the mechanism of AD and improve our therapeutic   3.   Brydon L, Roka F, Petit L,  et al., 1999, Dual signaling of
            strategy.                                             human Mel1a melatonin receptors via G(i2), G(i3), and

            Acknowledgments                                       G(q/11) proteins. Mol Endocrinol, 13: 2025–2038.
                                                                  https://doi.org/10.1210/mend.13.12.0390
            We thank all the technicians and core facility in the
            Analytical and Testing Center, Huazhong University of   4.   Huete-Toral F, Crooke A, Martinez-Aguila A, et al., 2015,
                                                                  Melatonin receptors trigger cAMP production and inhibit
            Science and Technology for their support.
                                                                  chloride movements in nonpigmented ciliary epithelial
            Funding                                               cells. J Pharmacol Exp Ther, 352: 119–128.
                                                                  https://doi.org/10.1124/jpet.114.218263
            This study is supported by Major Project of “Brain Science
            and Brain-inspired Research” (2022ZD0206800), the   5.   Liu Y, Ni C, Li Z,  et al., 2017, Prophylactic melatonin
            National Natural Science Foundation of China (82030032,   attenuates isoflurane-induced cognitive impairment in aged
            82261138555, 32070960, 31721002), Top-Notch Young     rats through hippocampal melatonin receptor 2-cAMP
                                                                  response element binding signalling. Basic Clin Pharmacol
            Talents Program of China of 2014, the Fundamental     Toxicol, 120: 219–226.
            Research Funds for the Central Universities (2023BR027)
            to Dr. Ling-Qiang Zhu, and the Hubei Provincial Natural      https://doi.org/10.1111/bcpt.12652
            Science Foundation (2022CFA004) to Dr. Ling-Qiang Zhu.   6.   Palmer AM, Burns MA, 1994, Selective increase in lipid
                                                                  peroxidation in the inferior temporal cortex in Alzheimer’s
            Conflict of interest                                  disease. Brain Res, 645: 338–342.
            The authors declare that they have no competing financial      https://doi.org/10.1016/0006-8993(94)91670-5
            interests in this paper.                           7.   Roy J, Tsui KC, Ng J, et al., 2021, Regulation of melatonin
                                                                  and neurotransmission in Alzheimer’s disease. Int J Mol Sci,
            Author contributions                                  22: 6841.
            Conceptualization: Dan Liu                            https://doi.org/10.3390/ijms22136841
            Formal analysis: He-Zhou Huang                     8.   Gagnon K, Godbout R, 2018, Melatonin and comorbidities
            Investigation: Xiang Wang, He-Zhou Huang              in children with autism spectrum disorder. Curr Dev Disord
            Writing – original draft: Xiang Wang                  Rep, 5: 197–206.
            Writing – review & editing: Xiang Wang, Dan Liu
                                                                  https://doi.org/10.1007/s40474-018-0147-0
            Ethics approval and consent to participate         9.   Savaskan E, Jockers R, Ayoub M,  et al., 2007, The MT2

            The animal experiments have been reviewed and approved   melatonin receptor subtype is present in human retina
                                                                  and decreases in Alzheimer’s disease. Curr Alzheimer Res,
            by the Medical Ethics Committee of Tongji Medical     4: 47–51.
            College of Huazhong University of Science and Technology
            (Approval ID: 2019S1873).                             https://doi.org/10.2174/156720507779939823
                                                               10.  Congdon EE, Sigurdsson EM, 2018, Tau-targeting therapies
            Consent for publication                               for Alzheimer disease. Nat Rev Neurol, 14: 399–415.
            Not applicable.                                       https://doi.org/10.1038/s41582-018-0013-z


            Volume 2 Issue 3 (2023)                         9                         https://doi.org/10.36922/an.0974
   86   87   88   89   90   91   92   93   94   95   96